Ovarian tissue cryopreservation and transplantation: 20 years experience in Bologna University.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 02 09 2022
accepted: 26 09 2022
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 2 11 2022
Statut: epublish

Résumé

To report the 20-year experience in ovarian tissue cryopreservation (OTC) and ovarian tissue transplantation (OTT) of the Bologna clinical center (Bologna, Italy). Retrospective cohort study. 1026 pediatrics and women aged between 2 and 38 years who underwent OTC and OTT between January 2002 to January 2022. Of the 1026 patients, 238 (22.8%) were pediatrics (≤ 17 years, Group 1) and 788 (77.2%) were adult women (range 18-38 years, Group 2). In Group 1, 184 (77.3%) patients had malignant diseases and 54 (22.7%) had non-malignant diseases. In Group 2, 746 (94.7%) patients had malignant diseases and 42 (5.3%) had non-malignant diseases. No real complications were observed during surgery. In all the samples analyzed most of the follicles were in the resting stage, while only a few follicles were growing. In both fresh and thawed samples, follicular density was higher in Group 1 than in Group 2 (p < 0.01). Regardless of age, good preservation of follicles and stroma was observed in fresh and thawed ovarian tissue by histological and immunohistochemical analyses (estrogen and progesterone receptors; Ki67 and Bcl2 markers; TUNEL). To date, out of 1026 total women, 812 (79.1%) had their tissue stored. Sixty-eight (6.6%) patients died from their primary disease. Twenty-four (2.3%) women performed 33 OTTs between December 2011 and January 2022. Restoration of menstruation was observed in 15 out of 17 menopausal women. Six pregnancies were achieved, two hesitated in abortion and four in the birth of healthy babies. OTC is the only fertility preservation technique applicable in pre-pubertal/pediatrics and in adult patients when stimulation for oocytes/embryos cryopreservation is not possible. The reported data can help future patients and physicians in their discussions and decisions about the need and possibilities of preserving ovarian function.

Identifiants

pubmed: 36313739
doi: 10.3389/fendo.2022.1035109
pmc: PMC9597685
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035109

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 Fabbri, Vicenti, Magnani, Paradisi, Lima, De Meis, Rossi, Raimondo, Casadio, Venturoli, Maffi and Seracchioli.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur J Cancer. 2013 Sep;49(13):2960-1
pubmed: 23731831
Acta Obstet Gynecol Scand. 2016 Sep;95(9):1015-26
pubmed: 27258933
Acta Obstet Gynecol Scand. 2020 Feb;99(2):213-221
pubmed: 31538662
J Pediatr Surg. 2007 May;42(5):862-4
pubmed: 17502200
Reprod Biomed Online. 2010 Dec;21(6):819-28
pubmed: 21050819
J Ovarian Res. 2016 Aug 24;9(1):50
pubmed: 27557782
Gynecol Endocrinol. 2019 Jun;35(6):470-472
pubmed: 30602343
Hum Reprod. 2017 May 1;32(5):1046-1054
pubmed: 28333228
Reprod Biomed Online. 2022 Mar;44(3):504-514
pubmed: 35151573
J Pediatr Adolesc Gynecol. 2014 Apr;27(2):95-7
pubmed: 24602303
Hum Reprod. 2017 Sep 1;32(9):1802-1811
pubmed: 29117320
Future Oncol. 2014 Mar;10(4):549-61
pubmed: 24754587
J Matern Fetal Neonatal Med. 2021 Jul;34(14):2391-2398
pubmed: 31500478
Haematologica. 2019 Aug;104(8):e360-e363
pubmed: 30765476
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997
J Assist Reprod Genet. 2017 Mar;34(3):325-336
pubmed: 28028773
Fertil Steril. 2021 Oct;116(4):1098-1106
pubmed: 34130800
Croat Med J. 2021 Jun 30;62(3):297-299
pubmed: 34212567
Hum Reprod. 2016 Sep;31(9):2031-41
pubmed: 27378768
Acta Obstet Gynecol Scand. 2019 May;98(5):630-637
pubmed: 30919447
Lancet Oncol. 2014 Sep;15(10):1129-36
pubmed: 25130994
Fertil Steril. 2020 Aug;114(2):388-397
pubmed: 32605799
Eur J Cancer. 2013 Mar;49(4):911-4
pubmed: 23084082
Reprod Biomed Online. 2018 Feb;36(2):188-196
pubmed: 29198423
J Assist Reprod Genet. 2018 Apr;35(4):561-570
pubmed: 29497953
Gynecol Endocrinol. 2016 Nov;32(11):881-885
pubmed: 27227875
Front Oncol. 2021 Jun 30;11:692834
pubmed: 34277437
Fertil Steril. 2016 Aug;106(2):467-74
pubmed: 27181924
Fertil Steril. 2014 Mar;101(3):795-804
pubmed: 24424364
Fertil Steril. 2021 May;115(5):1102-1115
pubmed: 33933173
Gynecol Oncol. 2010 May;117(2):385-6
pubmed: 20153882
Endocr Rev. 1996 Apr;17(2):121-55
pubmed: 8706629

Auteurs

Raffaella Fabbri (R)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Rossella Vicenti (R)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Valentina Magnani (V)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Roberto Paradisi (R)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Mario Lima (M)

Department of Medical and Surgical Sciences, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Pediatric Surgery Department, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.

Lucia De Meis (L)

Division of Gynaecology and Human Reproduction Physiopathology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.

Stefania Rossi (S)

Division of Gynaecology and Human Reproduction Physiopathology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.

Diego Raimondo (D)

Division of Gynaecology and Human Reproduction Physiopathology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.

Paolo Casadio (P)

Division of Gynaecology and Human Reproduction Physiopathology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.

Stefano Venturoli (S)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Michela Maffi (M)

Pediatric Surgery Department, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.

Renato Seracchioli (R)

Department of Medical and Surgical Sciences, Division of Gynaecology and Human Reproduction Physiopathology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH